Hasil Pencarian  ::  Simpan CSV :: Kembali

"Penyebab abortus iminens multifaktor. Penyebab terbesar adalah rendahnya kadar progesteron serum. Kadar kritis terendah progesteron serum untuk kelangsungan kehamilan adalah 10 ng/ml. 80 % pasien yang mengalami abortus kadar progesteronnya berada < 10 ng/ml. Pasien yang mengetahui kehamilannya mengalami perdarahan umumnya akan mengalami stress. Stress merupakan juga salah satu faktor terjadinya abortus. Pemberian substitusi progesteron alami (bukan progestogen) mempercepat hilangnya kontraksi uterus, dan mempercepat hilangnya perdarahan. Selain itu progesteron juga memiliki khasiat antikecemasan. Pemberian progesteron oral akan mengalami metabolisme di usus dan hati, sehingga tidak dapat dicapai kadar progesteron serum yang fisiologis, sedangkan pemberian progesteron supositoria diperoleh kadar serum yang fisiologik sehingga sangat efektif mencegah abortus iminens. (Med J Indones 2005; 14:258-62)

---

The causes of imminent abortion are multi-factorial. The biggest causal factor is the low level of serum progesterone level. The lowest critical level of serum progesterone for survivability of pregnancy is 10 ng/ml. Eighty percent of patients experiencing abortion showed that their progesterone level was < 10 ng/ml. Patients who realized that their pregnancy would experience hemorrhage generally would suffer from depression. Stress was one of the factors responsible for the occurence of abortion. Administration of natural progesterone substitution (not progestogen) accelerates the disappearance of uterine contractions, and speeds up the stoppage of bleeding. In addition, progesterone has the effect of anti-anxiety. Adminstration of oral progesterone would result in metabolism in the intestine and liver, such that physiological level of serum progesterone could not be reached, while administration of suppositoria progesterone would result in physiological level of serum, such that it was effective to prevent imminent abortion. (Med J Indones 2005; 14:258-62)"

"ABSTRACT

The Effect of Combination of Testosterone Enanthate (Te) and Depot Medroxyprogesterone Acetate (DMPA) Monthly Injection during a Year to Reproduction Hormone Levels in Serum of Fertile MenScope and methods of study: The effectiveness and safety of hormonal contraception for men have not been achieved. The development of methods to control fertility in men was more complex than in women. The objective of hormonal contraception in men is to cause a decrease in spermatozoa production, which should be reversible. Spermatogenesis is under the control of intra-testicular testosterone, which in turn is regulated by the gonadotropins FSH and LH.

Previous studies in which a combination of TE + DMPA, at a low dose (100 mg TE + 100 mg DMPA) and high dose (250 mg TE + 200 mg DMPA), were injected monthly for 3 months suggested a good prospect: sperm production were suppressed without disturbing the libido. However, neither of these could produce azoospermia consistently, and the effective dose was still uncertain. The present study was carried out to determine the effects of TE and DMPA combination, at low and high doses, on 20 fertile men. The drug combination was given as intra-muscular injection monthly for 6 months (suppression phase) followed by another 6 months of maintenance phase. Serum FSH, LH and testosterone were determined by radioimmunoassay (DPC) prior to treatment, and every 3 months until the twelfth month. The study was a randomized control trial by factorial design (time and dosage). Statistical analysis was by two-way ANOVA.

Findings and conclusions: The treatment of TE+DMPA in combination of low dose and high dose caused decreased male reproductive hormone levels. No difference was observed between the two treatments (p > 0.05) by LH: 3.06 mg/mL. FSH: 4.01 mg/mL, testosterone; 3.16 mg/mL at low dose and LH: 2.81 mg/mL, FSH: 4.03 mg/mL, testosterone: 2 .91 mg/mL at high dose. The hormone levels in the 3`d month were significantly lower compared to those of the pretreatment period (p < 0.01), and they were consistently decreased during the 12 months of observation by LH: 2.95 mg/mL, FSH: 3.14 mg/mL, testosterone: 2.76 mg/mL of different with baseline (0'hmonth) to LH: 6.06 mg/mL, FSH: 11.06 mg/mL, testosterone: 7.18 mg/mL up to 12'" month. While starting at the 9'h (LH: 1.77 mg/mL, FSH: 1.87mg/mL, testosterone: 1.62 mg/mL) and 12'h month (LH: 1.66 mg/mL, FSH: 1.80 mlU1mL, testosterone: 1.55 mg/mL) the decrease of hormone levels were seen but not significant (p > 0.05) with 6 th month (LH: 2.25 mg/mL, FSH: 2.20 mg/mL, testosterone: 2.05 mg/mL). It was concluded that injection of the combination of TE and DMPA, of low and high doses, every month for 12"' months could decrease the serum level of LH, FSH and testosterone in fertile men. The effect was suppression of the hormone levels and could be maintained during the 12 months period of observation.

---

ABSTRAKRuang lingkup dan cara penelitian : Kontrasepsi hormon untuk pria yang efektif dan aman sampai sekarang belum diperoleh. Hal ini disebabkan pengembangan cara pengendalian kesuburan pria lebih sulit daripada wanita. Metoda kontrasepsi hormon untuk pria bertujuan untuk menekan produksi sperma secara reversibel yaitu melalui hambatan sekresi hormon gonadotropin, sehingga kadar testosteron intra-testis menjadi rendah. Spermatogenesis dipengaruhi oleh kadar gonadotropin dan testosteron yang normal sedangkan pembentukan testosteron dari sl Leydig berkaitan dengan kadar LH dan FSH yang normal pula.Penyuntikan kombinasi dosis rendah 100 mg TE + 100 mg DMPA dan tinggi 250 mg TE + 200 mg DMPA tiap bulan selama 3 bulan oleh peneliti terdahulu dianggap mempunyai prospek yang baik yaitu dapat menekan produksi sperma dan potensi sakit serta libido tidak terganggu, namun kedua kombinasi obat tersebut belum dapat menimbulkan azoospermia yang konsisten sehingga efektivitas dari dosis obat belum diketahui. Untuk memantau efektivitas dalam penggunaan kedua dosis TE dan DMPA perlu dilakukan penelitian dengan modifikasi lama pemberian dari kombinasi dosis rendah dan tinggi pada 20 pria fertil terhadap penurunan kadar LH, FSH dan testosteron di serum selama 6 bulan (fase penekanan) dan 6 bulan berikutnya (fase pemeliharaan). Pengukuran kadar hormon dilakukan tiap 3 bulan sekali dengan metoda RIA (Radioimmunoassay). Rancangan percobaan menggunakan uji klinis acak terkontrol berpola faktorial (waktu dan dosis). Analisis statistik dengan uji sidik ragam 2 faktor.Hasil dan kesimpulan: Penyuntikan kombinasi dosis rendah maupun tinggi menyebabkan penurunan kadar LH, FSH dan testosteron serum pria fertil. Penurunan kadar hormon tersebut akibat pemberian kedua dosis TE dan DMPA tidak berbeda (p > 0.05) baik pada dosis rendah yaitu LH: 3.06 mg/mL, FSH: 4.01mg/mL, testosteron: 3.16 mg/mL maupun dosis tinggi LH: 2.81 mg/mL, FSH: 4.03 mg/mL, testosteron: 2.91 mg/mL. Bulan ke 0, 3, 6, 9 dan 12 memberikan pengaruh (p < 0.01) terhadap penurunan kadar hormon mulai bulan ke 3 yaitu LH: 2.95 mg/mL, FSH: 3.14 mg/mL, testosteron: 2.76 mg/mL dibanding kadar awal (bulan ke 0) yaitu LH: 6.06 mg/mL, FSH: 11.06 mg/mL, testosteron 7.18 mg/mL dan berlanjut terus sampai bulan ke 12. Pada bulan ke 9 (LH:1.77 mg/mL, FSH: 1,87 mg/mL, testosteron: 1.62 mg/mL) dan bulan ke 12 (LH: 1.66 mg/mL, FSH:1.80 mg/mL, testosteron: 1.55 mg/mL) walaupun terjadi penurunan namun tidak berbeda (p > 0.05) dengan bulan ke 6 (LH: 2.25 mg/mL, FSH: 2.20 mg/mL, testosteron: 2.05 mg/mL). Berdasarkan hasil ini dapat disimpulkan bahwa penyuntikan kombinasi TE+DMPA pada dosis rendah dan tinggi setiap bulan pada pria fertil dapat menurunkan kadar LH, FSH dan testosteron di serum secara konsisten selama 6 bulan dan penurunan tersebut dapat dipertahankan secara konsisten selama 6 bulan berikutnya."

"Guna memperoleh profil reseptor estrogen dan progesteron sitosol baik di dalam jaringan endometriosis maupun endometrium pada pasien dengan atau tanpa endometriosis dilakukan suatu kajian iris-silang yang melibatkan 43 wanita infertil. Ini terdiri dari 31 (72,09%) kasus endometriosis dan 12 (27,91%) kasus nir-endometriosis; umur rerata masing-masing 32 ± 4 tahun dan 32 ± 3 tahun, dengan rerata panjang siklus haid masing-masing 31 ± 8 hari dan 29 ± 1 hari. Jaringan endometriosis diperoleh dengan eksisi selama tindakan laparoskopi operatif, sementara endometrium diperoleh dengan biopsi menyusul tindakan histeroskopi. Tindakan ini dilaksanakan dalam kurun periovulasi (Hari 13-18 siklus haid). Kandungan reseptor steroid seks dalam sitosol diukur secara kuantitatif menggunakan cara tera imunoenzimatik, dan dihitung sebagai reseptor steroid seks/protein sitosol (fmol/ml sitosol). Ditemukan bahwa konsentrasi rerata reseptor estrogen sitosol dalam jaringan terkait adalah: 512.99 fmol/ml di ovarium endometriotik dibandingkan dengan 2369.17 fmol/ml di ovarium normal, dan 601.02 fmol/ml di peritoneum endometriotik dibandingkan dengan 9607.61 fmol/ml di peritoneum normal, serta masing-masing 99.28 fmol/ml dan 608.33 fmol/ml di endometrium wanita dengan dan tanpa endometriosis. Konsentrasi rerata reseptor progesteron sitosol yang ditemukan di masing-masing jaringan adalah 50.64 fmol/ml di ovarium endometriotik dibandingkan 6496.42 fmol/ml di ovarium normal dan 1631.40 fmol/ml di peritoneum endometriotik dibandingkan 12466.99 fmol/ml di peritoneum normal, serta masing-masing 21.26 fmol/ml dan 599.61 fmol/ml di endometrium wanita dengan dan tanpa endometriosis. Tidak terdapat perbedaan bermakna pada konsentrasi reseptor antara masing-masing jaringan menurut asal to-pografiknya. Namun demikian, hasil ini dapat memperkirakan bahwa daya-tanggap terhadap penanganan hormonal pada kasus-kasus endometriosis akan bergantung pada kandungan reseptor steroid seks sitosol pada jaringan yang sakit, dan lesi-lesi peritoneal mungkin akan memberikan tanggapan yang lebih baik daripada yang di sisi lain. Diperlukan uji klinis lebih lanjut. (Med J Indones 2005; 14: 133-41)

---

In order to have a profile of cytosolic estrogen and progesterone receptors in either endometriotic tissue or endometrium in patients with and without endometriosis a cross-sectional study was performed involving 43 infertile women. They consisted of 31 (72.09%) en-dometriosis and 12 (27.91%) non-endometriosis cases; their average age was 32 ± 4 years and 32 ± 3 years respectively, with the ave-rage length of menstrual cycle 31 ± 8 days and 29 ± 1 days respectively. The endometriotic tissue was obtained by excision during ope-rative laparoscopy procedure, while the endometrium was obtained by biopsy following hysteroscopy procedure. These procedures were conducted within the periovulatory period (on Day 13-18 of the cycle). The sex steroid receptor content in the cytosol was measured quantitatively using enzyme-immunoassay method, and calculated as sex steroid receptor/cytosol protein (fmol/ml cytosol). It was found that the average cytosolic estrogen receptor concentration in the respective tissues were 512.99 fmol/ml in the endometriotic ovary compared with 2369.17 in normal ovary and 632.18 fmol/ml in the endometriotic peritoneum compared with 9607.61 fmol/ml in normal peritoneum; while 99.28 fmol/ml and 608.33 fmol/ml in the endometrium of women with endometriosis and those without endometriosis respectively. The average cytosolic progesterone receptor concentration found in the respective tissues were 50.64 fmol/ml in the endometriotic ovary compared with 6469.42 fmol/ml in normal ovary and 1631.40 fmol/ml in endometriotic peritoneum compared with 12466.99 in normal peritoneum, while 21.26 fmol/ml and 599.61fmol/ml in the endometrium of women with endometriosis and those without endometriosis respectively. There is no significant difference in the receptor concentration between each tissue according to its topographic origin. However, this result may assume that the responsivity on hormonal treatment in endometriosis cases will depend on the cytosolic sex steroid receptor content in the sick tissues, and the peritoneal lesions will possibly give better response than those in other sites. A further clinical trial is necessary. (Med J Indones 2005; 14: 133-41)"

"Tujuan penelitian ini adalah untuk memperoleh gambaran perjalanan asma pada kehamilan yaitu gambaran gejala asma pada trimester I, II, III dan setelah melahirkan. Parameter untuk menilai perbaikan maupun perburukan gejala asma adalah dengan menilai perbaikan skor gejala asma menggunakan kartu harlan yang mencakup skor batuk, gangguan tidur, aktiviti, mengi, penggunaan pelega inhalasi serta nilai APE. Penelitian ini bersifat studi prospektif dikerjakan di poliklinik asma Departemen Pulmonologi dan llmu Kedokteran Respirasi FKUI RS Persahabatan serta poli kebidanan dan kandungan RS Persahabatan. Penelitian ini melibatkan 33 pasien asma termasuk kelompok asma intermiten, persisten ringan dan persisten sedang. Kami melakukan evaluasi klinis sesuai skor gejala asma dalam kartu harlan setiap bulan, laboratorium dan spirometri pada trimester I kehamilan dilanjutkan evaluasi klinis setiap bulan di trimester II, evaluasi klinis setiap bulan serta laboratorium ditrimester III dan evaluasi klinis beserta spirometri pada satu bulan pascapersalinan.

---

The purpose of this study is to obtain an overview of the journey of asthma in Pregnancy is a description of asthma symptoms in the I, II, III trimesters and after childbirth. The parameter to assess the improvement or worsening of asthma symptoms is to assess Improvement of asthma symptom scores using Harlan cards which include cough scores, disorders sleep, activity, wheezing, use of inhalation relievers and APE scores. This research is a study prospective is carried out at the asthma polyclinic of the Department of Pulmonology and Medicine Respiration of FKUI Friendship Hospital and obstetrics and gynecology polyclinic of Friendship Hospital. This study involved 33 asthma patients including intermittent, persistent asthma groups

mild and moderately persistent. We conducted clinical evaluations according to asthma symptom scores in Harlan card every month, laboratory and spirometry in the first trimester of pregnancy are continued clinical evaluation every month in the second trimester, clinical evaluation every month and laboratories in the third trimester and clinical evaluation along with spirometry in one month postpartum."

"Latar belakang. Endometriosis adalah suatu penyakit radang kronik yang dicirikan dengan adanya pertumbuhan jaringan mirip endometrium yang dapat ditemukan pada peritoneum, ovarium, dan septum retrovagina. Penyakit ini merupakan penyakit multifaktorial yang dapat disebabkan oleh faktor genetik dan lingkungan. Selain itu, faktor hormonal diketahui mempengaruhi perkembangan dan klinis endometriosis. Resistensi hormon progesteron merupakah salah satu penyebab terjadinya endometriosis karena sering dihubungkan dengan rendahnya kadar dan aktivitas kerja reseptor hormon progesteron pada endometriosis. Polimorfisme gen reseptor progesteron (PROGINS=progesterone receptor gene polymorphism) diketahui berkaitan dengan risiko endometriosis. Penelitian ini bertujuan untuk mengetahui hubungan polimorfisme gen reseptor progesteron (PR) rs139646398 dengan endometriosis di Indonesia. Metode penelitian. Penelitian cross sectional ini menggunakan 30 sampel jaringan endometriosis ovarium dari wanita penderita endometriosis dan 17 jaringan endometrium dari wanita tanpa endometriosis. Sampel DNA dari subjek diisolasi, dilakukan PCR, diikuti dengan proses elektroforesis, dan dilanjutkan dengan DNA sequencing. Hasil. Hasilnya dianalisis secara statistik dengan uji Fisher. Tidak ditemukan perbedaan yang signifikan frekuensi genotip rs139646398 dari gen PR pada endometriosis ovarium dan kontrol (p=0,638). Penelitian ini menunjukkan tidak adanya hubungan antara polimorfisme gen reseptor progesteron rs139646398 dengan endometriosis di Indonesia. Kesimpulan. Penelitian ini menunjukkan tidak adanya hubungan antara polimorfisme gen reseptor progesteron rs139646398 dengan endometriosis di Indonesia.

---

Endometriosis is a chronic inflammatory disease characterized by the growth of endometrial-like tissues that can be found in peritoneum, ovary, and retrovaginal septum. This disease is a multifactorial disease caused by genetic and environmental factors. In addition, hormonal factors are known to influence the development and clinical symptom of endometriosis. Progesterone resistance is one of the causes of endometriosis. It is often associated with low levels or activity of hormone progesterone receptor in endometriosis patients. Progesterone receptor gene polymorphism (PROGINS) is known to be associated with the risk of endometriosis. This study aims to determine the relationship between progesterone receptor (PR) gene polymorphism rs139646398 with endometriosis.

Methods. This cross sectional study used 30 endometriosis ovary samples from women suffered endometriosis and 17 endometrium tissues from women without endometriosis. DNA samples from subjects were isolated, PCR was carried out, then followed by electrophoresis, and continued with DNA sequencing.

Results. The results were statistically analysed by Fisher’s test. There was no statistically significant difference in genotype frequency of rs139646398 of the PR gene in ovarian endometriosis and controls (p=0.638).

Conclusion. This study shows no relationship between progesterone receptor gene polymorphism rs139646398 and endometriosis in Indonesia."

"The development of male hormonal contraception is based on a decrease in sperm concentration without affecting libido and sexual potency. The combination of depot medroxy progesterone acetate (DMPA) + extract of Javanese long pepper (JLP) with dosages of 0.94 mg and 1.88 mg decreas es the concentration of spermatozoa. However, it remains unknown whether the combination influences body weight, hematology, and blood biochemistry. Therefore, it is necessary to investigate the effect of DMPA + JLP extracts on the body weight, hematology, and blood biochemistry of male rats (RattusnorvegicusL.) using Sprague-Dawley strains. The research uses a completely randomized design (CRD); one group control and two treatment groups. In the first group, the castrated rats were given oral administration extracts of JLP (CJ) with doses of 0, 0.94, 1.88, 2.82, and 3.76 mg. In the second group, the rats were injected with 1.25mg DMPA and given an oral administration extract of JLP. Injection was given in week-0 and 12. Administration was conducted every day from week 7-18. Analysis of the normality and homogeneity of data is done before the ANOVA test. Data that is abnormal and not homogeneous are tested with non-parametric statistical Kruskal-Wallis. This study shows that the combination of minimal doses of DMPA and administration variousdoses of extracts of JLP does not affect body weight and hematology (erythrocyte, hemoglobin, hematocrite), and the blood biochemistry of rats, such as the values of SGPT, SGOT, HDL, and triglycerides (p< 0.05), but rather the total cholesterol and LDL (p< 0.05). Furthermore, it is concluded that the combination of the minimal dosage of DMPA and weaned various dosages of JLP extracts affect the total value and LDL cholesterol but do not influence body weight, nor hematology and blood biochemistry. Such combinations can be drawn on for asafe male contraceptive model t by taking into account the value of the total cholesterol and LDL during its use."

"Latar belakang: Resistensi progesteron akibat gangguan ekspresi reseptor progesteron pada jaringan endometriosis telah diketahui menjadi faktor yang memperberat kondisi klinis pasien endometriosis. Tujuan penelitian ini adalah untuk menganalisis tingkat metilasi DNA pada promoter gen PR-B pada berbagai jaringan endometriosis seperti eutopik endometrium, lesi ektopik peritoneum, endometrioma dan darah menstruasi serta pengaruhnya terhadap ekspresi mRNAnya dibandingkan dengan kontrol endometrium normal; untuk mengetahui patomekanisme endometriosis pada berbagai lokasi terkait dengan resistensi progesteron.Metode: Penelitian ini menggunakan desain potong lintang yang melibatkan 20 sampel untuk masing-masing kelompok kasus dan kontrol. Tingkat metilasi DNA dari gen PR-B diukur menggunakan metode Methylated Specific PCR MSP lalu intensitas pita di dalam gel agarose dihitung dengan software ImageJ. Presentase intensitas pita pada sampel dibandingkan dengan kontrol positif disebut dengan tingkat metilasi DNA. Pengukuran ekspresi relatif mRNA PR-B menggunakan qRT-PCR dua tahap dan analisis dilakukan dengan metode Livak.Hasil: Dari penelitian ini didapatkan perbedaan bermakna antara tingkat metilasi DNA gen PR-B pada jaringan endometriosis ektopik peritoneum 72,4 termetilasi , endometrioma 85 termetilasi dan eutopik endometrium 72,21 termetilasi dibandingan dengan kontrol p

---

Background: Progesterone resistance, due to alteration of progesterone receptor PR expression in endometriosis, was known as a disrupt factor in response to progesterone. The aim of this study is to analyze DNA methylation level on PR B promoter in various tissues include eutopic endometrium, ectopic peritoneal, endometrioma and menstrual blood from endometriosis patient as well as the implication on it's mRNA relatif expression compare with normal endometrium control to know the patomechanisms of endometriosis in various lession in term of progesterone resistance.

Methods: It was a cross sectional study, involved 20 sample for both patient and control. DNA isolate from each sample were converted by bisulfite conversion. DNA methylation level of PR B gene was analysis by Methylated Specific PCR MSP method, then band intensity in gel agarose was measured by ImageJ software. Percentage of band intensity in sample compared with positive control was determined as DNA methylaton level. Quantitative real time PCR was conducted to assess expression of mRNA PR B for each sample and Livak method was used to analysis it's relatif expression compare with control.

Result: There were significant different of methylation level of PR B gene in ectopic peritoneal endometriosis 72,40 methylated , endometrioma 85 methylated and eutopic endometrium 72,21 methylated compared with control p"

"Uji klinis acak tersamar ganda paralel ini merupakan penelitian pendahuluan, bertujuan mengetahui pengaruh suplementasi serat larut dan diet rendah kalori seimbang (DRKS) selama 4 minggu terhadap kadar kolesterol low-density lipoprotein (LDL) serum pada obes I usia 30−50 tahun. Sejumlah 31 subyek dipilih dengan kriteria tertentu dan dibagi menjadi dua kelompok dengan randomisasi blok, 15 orang kelompok perlakuan (KP) dan 16 orang kelompok kontrol (KK). Subyek KP mendapat serat larut psyllium husk (PH) 8,4 g/hari dan DRKS 1200 kkal/hari, sedangkan subyek KK mendapat plasebo dan DRKS 1200 kkal/hari. Data terdiri atas usia, indeks massa tubuh (IMT), asupan zat gizi, serta kadar kolesterol LDL serum. Pemeriksaan kolesterol LDL dilakukan pada awal dan akhir penelitian. Analisis data menggunakan uji t tidak berpasangan dan Mann-Whitney, batas kemaknaan 5%. Karakteristik data dasar dan sebaran subyek kedua kelompok sebanding. Analisis lengkap dilakukan pada 28 subyek (KP dan KK masing-masing 14 subyek). Suplementasi ditoleransi baik dan tidak ditemukan efek samping serius. Median usia subyek KP dan KK berturut-turut 35,0 (30−45) tahun dan 34,50 (30−48) tahun serta rerata IMT 28,0 ± 1,1 kg/m2 dan 27,2 ± 1,4 kg/m2. Rerata kadar kolesterol LDL serum awal KP 137,0 ± 37,0 mg/dL dan KK 134,4 ± 29,1 mg/dL. Defisit energi KP lebih rendah tidak signifikan (p = 0,62) dibandingkan KK, berturut-turut -282,0 ± 482,6 kkal/hari dan -331,8 ± 578,3 kkal/hari. Persentase asupan energi terhadap anjuran KP (94,2 ± 18,5%) lebih tinggi signifikan (p = 0,02) daripada KK (85,4 ± 22,9%). Asupan karbohidrat (KH) total KP (613,1 ± 134,5 kkal/hari) lebih tinggi signifikan (p = 0,02) dibandingkan KK (545,4 ± 161,1 kkal/hari). Asupan protein, lemak total, dan kolesterol KP dan KK sesuai rekomendasi NCEP-ATP III. Pada kedua kelompok, asupan asam lemak jenuh cenderung tinggi, tetapi asupan asam lemak tak jenuh tunggal dan jamak rendah. Asupan serat subyek KP 17,2 ± 2,8 g/hari dan KK 8,6 (5,2−15,2) g/hari. Dengan suplementasi PH tidak tercapai rekomendasi asupan serat. Persentase asupan KH sederhana terhadap energi total KP 11,5±5,4% lebih tinggi signifikan (p = 0,00) dibandingkan KK 6,0 (1,2524,2)%. Penurunan kadar kolesterol LDL serum KP -2,1 ± 16,2 mg/dL lebih sedikit tidak signifikan (p = 0,15) dibandingkan pada KK -10,9 ± 15,3 mg/dL. Penelitian ini belum dapat membuktikan suplementasi PH 8,4 g/hari dan DRKS 1200 kkal/hari selama 4 minggu lebih baik dalam menurunkan kadar kolesterol LDL serum dibandingkan plasebo pada subyek obes I.

---

This parallel double blind randomized clinical trial is a preliminary study that aims to investigate the effect of soluble fiber supplementation 8.4 g/day and lowcalorie balanced diet (LCBD) for 4 weeks on serum low-density lipoprotein (LDL) cholesterol level in obese I, aged 30−50 years old. A total of 31 subjects were selected using certain criteria and randomly allocated to one of two groups using block randomization; 15 subjects for treatment (T) group and 16 subjects for control (C) group, respectively. The T group received psyllium husk (PH) 8.4 g/day and LCBD 1200 kcal/day, and the C group received placebo and LCBD 1200 kcal/day. Data include age, body mass index (BMI), intake of energy, macronutrient, and fiber, as well as serum LDL cholesterol level. Serum LDL cholesterol level was examined before and after treatment. Statistical analyses include independent t-test and Mann-Whitney with significance level of 5%. Subjects characteristics of the two groups at baseline was not statistically different. Twenty eight subjects (14 subjects in each group) completed the intervention. Supplementation was well tolerated and there were no serious adverse events. The mean age in T and C group was 35.0 (30.0−45.0) and 34.5 (30.0−48.0) years, respectively, and BMI was 28.0 ± 1.1 and 27.2 ± 1.4 kg/m2, respectively. The pretreatment serum LDL cholesterol level in T and C group was 137.0 ± 37.0 and 134.4 ± 29.1 mg/dL, respectively. Energy deficit in T group was insignificantly lower (p = 0.62) than in C group; -282.0 ± 482.6 and -331.8 ± 578.3 kcal/day, respectively. Percentage of energy intake to recommendation in T group (94.2 ± 18.5%) was significantly higher (p = 0.02) than that in C group (85.4 ± 22.9%). Total carbohydrate (CHO) intake in T group (613.1 ± 134.5 kcal/day) was significantly higher (p = 0.02) than in C group (545.4 ± 161.1 kcal/day). Total protein, fat, and cholesterol intake were similar to the NCEP-ATP III recommendation in both groups. Intake of SAFA was higher than recommended, meanwhile PUFA and MUFA intake were lower than those recommended in both groups. Dietary fiber intake in T and C group was 17.2 ± 2.8 and 8.6 (5.2−15.2) g/day, respectively. During the intervention, PH supplementation did not meet the recommendation. Percentage of simple CHO to total energy in T group 11.5±5.4% was significantly higher (p = 0.00) than in C group 6.0 (1.2524.2)%. PH supplementation decreased serum LDL cholesterol level (-2.1 ± 16.2 mg/dL) lower than placebo (-10.9 ± 15.3 mg/dL), but not significant different (p = 0.15). This study shows that PH supplementation 8.4 g/day in combination with LCBD 1200 kcal/day for 4 weeks in obese I aged 30−50 years old is not proven to decrease the serum LDL cholesterol level."